Sana Health, led by StartUp Health community member Richard Hanbury, is advancing toward global scale with its innovative audiovisual neuromodulation device. The company has reached a major regulatory milestone with an FDA De Novo grant for neuropathic pain, creating a new class of audio-visual neuromodulation, following earlier regulatory approval from Health Canada. Designed to address neuropathic pain and PTSD, Sana’s non-invasive technology offers an alternative to long-term reliance on opioids and gabapentinoids. With ongoing research funded by the U.S. Department of Defense and trials underway in the VA system and internationally, Sana Health is positioning itself as a foundational component of future multimodal pain and mental health care.

🌍 Global Expansion: Sana Health is scaling internationally following regulatory approvals in Canada and the U.S., with active studies in the VA system and Israel focused on neuropathic pain and PTSD.

💡 Innovative Technology: Sana’s device uses audiovisual neuromodulation to influence brain states associated with relaxation, recovery, and reduced pain perception, introducing a new class of regulated brain health therapy.

🏥 FDA De Novo Grant: Sana Health has received an FDA De Novo grant for neuropathic pain, establishing the first regulatory pathway in the US for audio-visual neuromodulation, following earlier approval by Health Canada.

🇮🇱 International Studies: Clinical studies are underway in the U.S. and Israel, including work with combat-injured veterans experiencing both PTSD and chronic pain, with early results showing clinically meaningful improvements.

💊 Reducing Medication Burden: In pivotal data submitted to the FDA, patients using Sana’s device demonstrated a 78% reduction in gabapentinoid use, highlighting its potential to reduce reliance on medications with significant side effects.

🔬 Department of Defense Partnership: Sana Health has secured substantial non-dilutive funding from the U.S. Department of Defense to support PTSD research, with trials conducted within the VA system showing significantly improved outcomes when combined with standard care.

🌱 Multimodal Care Vision: Sana Health is built for a future where pain and mental health care move toward multimodal models that combine neuromodulation, therapy, and medication when appropriate.

🚀 Investment and Collaboration Opportunities: Sana Health is actively seeking investors and strategic partners to support early commercial traction and integrate its technology into at-home pain and mental health platforms globally.